About time the directors did their job and educated the market as to what a more appropriate value would be. Allowing TBR shares to be sold off at the current price would have to bring into question whether the board is acting in the best interest of the companies. At $1,830 gold I estimate the asset backing to be $4.60 a share and this excludes the value of the TBR shares to be sold by Morgan Stanley, values the EKJV at the NST offer and the Philippines embarrassment at ZERO.
- Forums
- ASX - By Stock
- TBR
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-11
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TBR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.93 |
Change
0.000(0.00%) |
Mkt cap ! $230.8M |
Open | High | Low | Value | Volume |
$5.00 | $5.00 | $4.93 | $8.398K | 1.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 462 | $4.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.00 | 4864 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | 4.850 |
1 | 2079 | 4.800 |
2 | 2250 | 4.600 |
1 | 538 | 4.500 |
1 | 550 | 4.310 |
Price($) | Vol. | No. |
---|---|---|
4.960 | 1 | 1 |
4.970 | 2 | 1 |
5.120 | 1000 | 1 |
5.200 | 200 | 1 |
5.500 | 100 | 1 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
TBR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online